Credit Suisse Ag Protagonist Therapeutics, Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Credit Suisse Ag holds 63,024 shares of PTGX stock, worth $2.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,024

Previous 62,517 0.81%

Holding current value

$2.8 Million

Previous $1.43 Million 27.22%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$21.79 - $32.15 $11,047 - $16,300	507 Added 0.81%	63,024 $1.82 Million
Q4 2023 Feb 08, 2024	BUY	$14.05 - $23.44 $174,276 - $290,749	12,404 Added 24.75%	62,517 $1.43 Million
Q3 2023 Nov 13, 2023	SELL	$16.68 - $23.66 $212,186 - $300,978	-12,721 Reduced 20.25%	50,113 $835,000
Q2 2023 Aug 11, 2023	BUY	$18.02 - $29.36 $447,490 - $729,096	24,833 Added 65.35%	62,834 $1.74 Million
Q1 2023 May 10, 2023	BUY	$10.78 - $25.38 $72,915 - $171,670	6,764 Added 21.65%	38,001 $874,000
Q4 2022 Feb 13, 2023	SELL	$7.36 - $11.17 $5,851 - $8,880	-795 Reduced 2.48%	31,237 $340,000
Q3 2022 Nov 10, 2022	BUY	$7.86 - $11.71 $1,705 - $2,541	217 Added 0.68%	32,032 $270,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $25.52 $7,645 - $27,638	-1,083 Reduced 3.29%	31,815 $251,000
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $106,197 - $164,164	4,550 Added 16.05%	32,898 $779,000
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $11,512 - $24,226	653 Added 2.36%	28,348 $969,000
Q3 2021 Nov 12, 2021	BUY	$12.95 - $49.69 $3,108 - $11,925	240 Added 0.87%	27,695 $491,000
Q2 2021 Aug 16, 2021	BUY	$25.57 - $44.88 $158,917 - $278,929	6,215 Added 29.26%	27,455 $1.23 Million
Q1 2021 May 14, 2021	SELL	$19.02 - $31.15 $562,668 - $921,510	-29,583 Reduced 58.21%	21,240 $549,000
Q4 2020 Feb 12, 2021	BUY	$18.49 - $25.13 $431,686 - $586,710	23,347 Added 84.97%	50,823 $1.03 Million
Q3 2020 Nov 13, 2020	BUY	$15.19 - $22.4 $417,360 - $615,462	27,476 New	27,476 $537,000

Others Institutions Holding PTGX

# of Institutions

195

Shares Held

58.7M

Call Options Held

20.8K

Put Options Held

109K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.18B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account